Press release
Liposomal Drug Delivery Devices Market Report, Share, Research And Forecast 2024-2033
Liposomal Drug Delivery Devices Market Report
As per the report, the liposomal drug delivery devices market size has grown rapidly in recent years. It will grow from $4.52 billion in 2023 to $5.02 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The liposomal drug delivery devices market size is expected to see rapid growth in the next few years. It will grow to $7.71 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3349&type=smp
Global Increase In Cancer Cases Fuels Growth Of Liposomal Drug Delivery Devices Market
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the liposomal drug delivery devices market during the forecast period. Liposomal drug delivery systems are used as targeted therapy for cancer treatment in radiation therapy, chemotherapy, and surgical resection. According to the American Cancer Society, there were 1.9million new cases and 0.6 million cancer deaths in 2021 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the liposomal drug delivery devices market over the forthcoming years.
Strategic Collaborations And Innovations In The Liposomal Drug Delivery Devices Market
Several big companies are undertaking various strategic initiatives such as collaborations and new product development, which is likely to become a major trend in the liposomal drug delivery devices market. Various companies are coming together to develop liposomal drug delivery systems to expand their product portfolio and operations worldwide. For instance, in 2021, MindMed is an Israeli creative drug development company, announced the execution of a Memorandum of Understanding regarding the introduction of an exclusive collaborative development program to optimize the supply of particular psychedelic drug candidates, leveraging Nextage's proprietary Brain Targeting Liposome System (BTLS) supply technology, for which it has a license. In March 2020, FUJIFILM Corporation announced its decision to offer contract services of process development and manufacturing of liposome formulations to its partners seeking drug delivery formulations that are designed to deliver the therapeutic to the affected sites.
The liposomal drug delivery devices market covered in this report is segmented -
1) By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types
2) By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy
3) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=3349&type=discount
Major companies operating in the liposomal drug delivery devices market report are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Medtronic plc, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan NV, Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Ipsen SA, Novavax Inc., Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Tolmar Pharmaceuticals Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, Taiwan Liposome Company, T&T Scientific Corporation
Contents of the report:
1. Executive Summary
2. Liposomal Drug Delivery Devices Market Report Structure
3. Liposomal Drug Delivery Devices Market Trends And Strategies
4. Liposomal Drug Delivery Devices Market - Macro Economic Scenario
5. Liposomal Drug Delivery Devices Market Size And Growth
…..
27. Liposomal Drug Delivery Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liposomal Drug Delivery Devices Market Report, Share, Research And Forecast 2024-2033 here
News-ID: 3578924 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Liposomal
What is Liposomal Vitamin C? | ONS & FSMP Guide
What Does "Liposomal" Mean? Understanding Liposomal Vitamin C.
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/wechat_2025-08-06_015004_689.png
Modern supplements promise more than ever, yet many nutrients break down before your body can use them. SINOFN Health harnesses liposomal technology to protect vitamins like vitamin C in tiny phospholipid spheres-so they glide through digestion intact and deliver maximum potency.
How Liposomes Work
*
They encapsulate water-soluble nutrients at their core or embed fat-soluble compounds in their lipid layers.
*
When liposomes reach the…
Rising Prevalence Of Cancer Fuels Growth In Liposomal Doxorubicin Market: A Sign …
The Liposomal Doxorubicin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Liposomal Doxorubicin Market Size and Projected Growth Rate?
The liposomal doxorubicin market has also shown strong growth in recent years. It is expected to grow from $1.23 billion in 2024 to $1.32…
Key Trend Reshaping the Liposomal Drug Delivery Devices Market in 2025: Strategi …
What industry-specific factors are fueling the growth of the liposomal drug delivery devices market?
The global increase in cancer cases is expected to bolster the liposomal drug delivery devices market in the future. These delivery systems offer targeted treatments for cancer through radiation therapy, chemotherapy, and surgical resection. For example, data from UK-based charity, Macmillan Cancer Support, in June 2022, revealed a cancer prevalence of 3 million in 2022, which is…
Liposomal Supplements Market Research Report 2023
Liposomal Supplements Market
The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-31J7848/Global_and_China_Liposomal_Supplements_Market_Insights_Forecast_to_2027
North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029,…
Liposomal Supplements Market Research Report 2023 - valuates reports
The global Liposomal Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Liposomal Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of %…
Liposomal Doxorubicin Market - Powerful Delivery, Enhanced Outcomes: Empowering …
Newark, New Castle, USA - new report, titled Liposomal Doxorubicin Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liposomal Doxorubicin market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liposomal Doxorubicin market. The report offers an overview of the market, which…
